Endocrine Practice-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1247737, encodeId=c453124e7372b, content=请问这个期刊不OA的话还收版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac4f6476577, createdName=ms3000000912488688, createdTime=Wed Sep 07 19:00:43 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571030, encodeId=02c55e1030f7, content=大修回去后Awaiting AE Recommendation，要多久啊大概最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。最夏天 2017-04-26 16:23:00 发表: 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, beContent=最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182544, encodeId=73601182544f0, content=一审：2021.10.12-2021.11.14。需要注意杂志是双盲，因此花费了一些时间在通过技术审查上。二审：2021.11.24-2021.12.9。12.2才开始外审，差不多在技术编辑手上呆了一个星期。三审：2021.12.20-12.30。26号结束外审，30号accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9615485584, createdName=加油顺顺利利, createdTime=Sun Jan 09 16:04:07 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198295, encodeId=75dd1198295f1, content=偏重的研究方向：甲状腺 经验分享：一审大修，二审半个月后直接决定，没有送审，这种情况是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/f1848b9cd6a75f497bebcc3b4dc4cbf3.jpg, createdBy=2f2a5173746, createdName=老虎🐯, createdTime=Tue Mar 01 10:27:20 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101548, encodeId=96db110154881, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101547, encodeId=7815110154e42, content=关键词能否从题目中提炼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584830, encodeId=ab345848308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一审：24-Sep-2019，29-Oct-2019。给了大修。两个审稿人，还是比较认真的，总共有二十几条意见。 二审：26-Nov-2019，29-Dec-2019。给了小修，因为response里的一些图表没有上传。 三审：05-Jan-2020，14-Feb-2020。接收。 总体来说，还是非常效率。这本杂志在内分泌领域名声也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJibaCmkqDh1szchx6ZxPAKibTfzKVhZqTYn652p3NOPmswFfu95nic6R7rDJBABW6vdAAFxGgEucKA/0, createdBy=89752150161, createdName=脸圆圆学姐, createdTime=Sun Feb 16 15:35:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070872, encodeId=175810e0872e8, content=投稿之后就需要所有作者通过邮件确认吗？还是在接收之后才需要呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Nov 16 20:10:58 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570367, encodeId=f59f5e036785, content=大修回复过去编辑送外审还是直接编辑自己决定？第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细第一号第一号 2018-11-14 20:59:00 发表: 研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 02 00:00:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563203, encodeId=ca49563203bc, content=研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524c1935150, createdName=第一号第一号, createdTime=Wed Nov 14 20:57:00 CST 2018, time=2018-11-14, status=1, ipAttribution=)]

2022-09-07 ms3000000912488688

请问这个期刊不OA的话还收版面费吗？

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1247737, encodeId=c453124e7372b, content=请问这个期刊不OA的话还收版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac4f6476577, createdName=ms3000000912488688, createdTime=Wed Sep 07 19:00:43 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571030, encodeId=02c55e1030f7, content=大修回去后Awaiting AE Recommendation，要多久啊大概最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。最夏天 2017-04-26 16:23:00 发表: 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, beContent=最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182544, encodeId=73601182544f0, content=一审：2021.10.12-2021.11.14。需要注意杂志是双盲，因此花费了一些时间在通过技术审查上。二审：2021.11.24-2021.12.9。12.2才开始外审，差不多在技术编辑手上呆了一个星期。三审：2021.12.20-12.30。26号结束外审，30号accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9615485584, createdName=加油顺顺利利, createdTime=Sun Jan 09 16:04:07 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198295, encodeId=75dd1198295f1, content=偏重的研究方向：甲状腺 经验分享：一审大修，二审半个月后直接决定，没有送审，这种情况是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/f1848b9cd6a75f497bebcc3b4dc4cbf3.jpg, createdBy=2f2a5173746, createdName=老虎🐯, createdTime=Tue Mar 01 10:27:20 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101548, encodeId=96db110154881, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101547, encodeId=7815110154e42, content=关键词能否从题目中提炼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584830, encodeId=ab345848308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一审：24-Sep-2019，29-Oct-2019。给了大修。两个审稿人，还是比较认真的，总共有二十几条意见。 二审：26-Nov-2019，29-Dec-2019。给了小修，因为response里的一些图表没有上传。 三审：05-Jan-2020，14-Feb-2020。接收。 总体来说，还是非常效率。这本杂志在内分泌领域名声也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJibaCmkqDh1szchx6ZxPAKibTfzKVhZqTYn652p3NOPmswFfu95nic6R7rDJBABW6vdAAFxGgEucKA/0, createdBy=89752150161, createdName=脸圆圆学姐, createdTime=Sun Feb 16 15:35:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070872, encodeId=175810e0872e8, content=投稿之后就需要所有作者通过邮件确认吗？还是在接收之后才需要呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Nov 16 20:10:58 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570367, encodeId=f59f5e036785, content=大修回复过去编辑送外审还是直接编辑自己决定？第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细第一号第一号 2018-11-14 20:59:00 发表: 研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 02 00:00:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563203, encodeId=ca49563203bc, content=研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524c1935150, createdName=第一号第一号, createdTime=Wed Nov 14 20:57:00 CST 2018, time=2018-11-14, status=1, ipAttribution=)]

2019-05-16 12244fb8m28(暂无昵称)

大修回去后Awaiting AE Recommendation，要多久啊大概最夏天 2017-04-26 发表::
接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。最夏天 2017-04-26 16:23:00 发表:
审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。

最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。

167 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1247737, encodeId=c453124e7372b, content=请问这个期刊不OA的话还收版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac4f6476577, createdName=ms3000000912488688, createdTime=Wed Sep 07 19:00:43 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571030, encodeId=02c55e1030f7, content=大修回去后Awaiting AE Recommendation，要多久啊大概最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。最夏天 2017-04-26 16:23:00 发表: 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, beContent=最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182544, encodeId=73601182544f0, content=一审：2021.10.12-2021.11.14。需要注意杂志是双盲，因此花费了一些时间在通过技术审查上。二审：2021.11.24-2021.12.9。12.2才开始外审，差不多在技术编辑手上呆了一个星期。三审：2021.12.20-12.30。26号结束外审，30号accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9615485584, createdName=加油顺顺利利, createdTime=Sun Jan 09 16:04:07 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198295, encodeId=75dd1198295f1, content=偏重的研究方向：甲状腺 经验分享：一审大修，二审半个月后直接决定，没有送审，这种情况是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/f1848b9cd6a75f497bebcc3b4dc4cbf3.jpg, createdBy=2f2a5173746, createdName=老虎🐯, createdTime=Tue Mar 01 10:27:20 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101548, encodeId=96db110154881, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101547, encodeId=7815110154e42, content=关键词能否从题目中提炼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584830, encodeId=ab345848308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一审：24-Sep-2019，29-Oct-2019。给了大修。两个审稿人，还是比较认真的，总共有二十几条意见。 二审：26-Nov-2019，29-Dec-2019。给了小修，因为response里的一些图表没有上传。 三审：05-Jan-2020，14-Feb-2020。接收。 总体来说，还是非常效率。这本杂志在内分泌领域名声也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJibaCmkqDh1szchx6ZxPAKibTfzKVhZqTYn652p3NOPmswFfu95nic6R7rDJBABW6vdAAFxGgEucKA/0, createdBy=89752150161, createdName=脸圆圆学姐, createdTime=Sun Feb 16 15:35:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070872, encodeId=175810e0872e8, content=投稿之后就需要所有作者通过邮件确认吗？还是在接收之后才需要呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Nov 16 20:10:58 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570367, encodeId=f59f5e036785, content=大修回复过去编辑送外审还是直接编辑自己决定？第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细第一号第一号 2018-11-14 20:59:00 发表: 研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 02 00:00:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563203, encodeId=ca49563203bc, content=研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524c1935150, createdName=第一号第一号, createdTime=Wed Nov 14 20:57:00 CST 2018, time=2018-11-14, status=1, ipAttribution=)]

2022-01-09 加油顺顺利利

一审：2021.10.12-2021.11.14。需要注意杂志是双盲，因此花费了一些时间在通过技术审查上。二审：2021.11.24-2021.12.9。12.2才开始外审，差不多在技术编辑手上呆了一个星期。三审：2021.12.20-12.30。26号结束外审，30号accept。

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1247737, encodeId=c453124e7372b, content=请问这个期刊不OA的话还收版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac4f6476577, createdName=ms3000000912488688, createdTime=Wed Sep 07 19:00:43 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571030, encodeId=02c55e1030f7, content=大修回去后Awaiting AE Recommendation，要多久啊大概最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。最夏天 2017-04-26 16:23:00 发表: 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, beContent=最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182544, encodeId=73601182544f0, content=一审：2021.10.12-2021.11.14。需要注意杂志是双盲，因此花费了一些时间在通过技术审查上。二审：2021.11.24-2021.12.9。12.2才开始外审，差不多在技术编辑手上呆了一个星期。三审：2021.12.20-12.30。26号结束外审，30号accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9615485584, createdName=加油顺顺利利, createdTime=Sun Jan 09 16:04:07 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198295, encodeId=75dd1198295f1, content=偏重的研究方向：甲状腺 经验分享：一审大修，二审半个月后直接决定，没有送审，这种情况是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/f1848b9cd6a75f497bebcc3b4dc4cbf3.jpg, createdBy=2f2a5173746, createdName=老虎🐯, createdTime=Tue Mar 01 10:27:20 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101548, encodeId=96db110154881, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101547, encodeId=7815110154e42, content=关键词能否从题目中提炼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584830, encodeId=ab345848308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一审：24-Sep-2019，29-Oct-2019。给了大修。两个审稿人，还是比较认真的，总共有二十几条意见。 二审：26-Nov-2019，29-Dec-2019。给了小修，因为response里的一些图表没有上传。 三审：05-Jan-2020，14-Feb-2020。接收。 总体来说，还是非常效率。这本杂志在内分泌领域名声也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJibaCmkqDh1szchx6ZxPAKibTfzKVhZqTYn652p3NOPmswFfu95nic6R7rDJBABW6vdAAFxGgEucKA/0, createdBy=89752150161, createdName=脸圆圆学姐, createdTime=Sun Feb 16 15:35:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070872, encodeId=175810e0872e8, content=投稿之后就需要所有作者通过邮件确认吗？还是在接收之后才需要呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Nov 16 20:10:58 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570367, encodeId=f59f5e036785, content=大修回复过去编辑送外审还是直接编辑自己决定？第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细第一号第一号 2018-11-14 20:59:00 发表: 研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 02 00:00:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563203, encodeId=ca49563203bc, content=研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524c1935150, createdName=第一号第一号, createdTime=Wed Nov 14 20:57:00 CST 2018, time=2018-11-14, status=1, ipAttribution=)]

2022-03-01 老虎🐯

偏重的研究方向：甲状腺
经验分享：一审大修，二审半个月后直接决定，没有送审，这种情况是什么意思？

51 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1247737, encodeId=c453124e7372b, content=请问这个期刊不OA的话还收版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac4f6476577, createdName=ms3000000912488688, createdTime=Wed Sep 07 19:00:43 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571030, encodeId=02c55e1030f7, content=大修回去后Awaiting AE Recommendation，要多久啊大概最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。最夏天 2017-04-26 16:23:00 发表: 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, beContent=最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182544, encodeId=73601182544f0, content=一审：2021.10.12-2021.11.14。需要注意杂志是双盲，因此花费了一些时间在通过技术审查上。二审：2021.11.24-2021.12.9。12.2才开始外审，差不多在技术编辑手上呆了一个星期。三审：2021.12.20-12.30。26号结束外审，30号accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9615485584, createdName=加油顺顺利利, createdTime=Sun Jan 09 16:04:07 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198295, encodeId=75dd1198295f1, content=偏重的研究方向：甲状腺 经验分享：一审大修，二审半个月后直接决定，没有送审，这种情况是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/f1848b9cd6a75f497bebcc3b4dc4cbf3.jpg, createdBy=2f2a5173746, createdName=老虎🐯, createdTime=Tue Mar 01 10:27:20 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101548, encodeId=96db110154881, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101547, encodeId=7815110154e42, content=关键词能否从题目中提炼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584830, encodeId=ab345848308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一审：24-Sep-2019，29-Oct-2019。给了大修。两个审稿人，还是比较认真的，总共有二十几条意见。 二审：26-Nov-2019，29-Dec-2019。给了小修，因为response里的一些图表没有上传。 三审：05-Jan-2020，14-Feb-2020。接收。 总体来说，还是非常效率。这本杂志在内分泌领域名声也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJibaCmkqDh1szchx6ZxPAKibTfzKVhZqTYn652p3NOPmswFfu95nic6R7rDJBABW6vdAAFxGgEucKA/0, createdBy=89752150161, createdName=脸圆圆学姐, createdTime=Sun Feb 16 15:35:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070872, encodeId=175810e0872e8, content=投稿之后就需要所有作者通过邮件确认吗？还是在接收之后才需要呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Nov 16 20:10:58 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570367, encodeId=f59f5e036785, content=大修回复过去编辑送外审还是直接编辑自己决定？第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细第一号第一号 2018-11-14 20:59:00 发表: 研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 02 00:00:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563203, encodeId=ca49563203bc, content=研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524c1935150, createdName=第一号第一号, createdTime=Wed Nov 14 20:57:00 CST 2018, time=2018-11-14, status=1, ipAttribution=)]

2021-12-29 衣谷

审稿人会不会通过我提供的关键词检索创新性？

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1247737, encodeId=c453124e7372b, content=请问这个期刊不OA的话还收版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac4f6476577, createdName=ms3000000912488688, createdTime=Wed Sep 07 19:00:43 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571030, encodeId=02c55e1030f7, content=大修回去后Awaiting AE Recommendation，要多久啊大概最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。最夏天 2017-04-26 16:23:00 发表: 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, beContent=最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182544, encodeId=73601182544f0, content=一审：2021.10.12-2021.11.14。需要注意杂志是双盲，因此花费了一些时间在通过技术审查上。二审：2021.11.24-2021.12.9。12.2才开始外审，差不多在技术编辑手上呆了一个星期。三审：2021.12.20-12.30。26号结束外审，30号accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9615485584, createdName=加油顺顺利利, createdTime=Sun Jan 09 16:04:07 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198295, encodeId=75dd1198295f1, content=偏重的研究方向：甲状腺 经验分享：一审大修，二审半个月后直接决定，没有送审，这种情况是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/f1848b9cd6a75f497bebcc3b4dc4cbf3.jpg, createdBy=2f2a5173746, createdName=老虎🐯, createdTime=Tue Mar 01 10:27:20 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101548, encodeId=96db110154881, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101547, encodeId=7815110154e42, content=关键词能否从题目中提炼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584830, encodeId=ab345848308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一审：24-Sep-2019，29-Oct-2019。给了大修。两个审稿人，还是比较认真的，总共有二十几条意见。 二审：26-Nov-2019，29-Dec-2019。给了小修，因为response里的一些图表没有上传。 三审：05-Jan-2020，14-Feb-2020。接收。 总体来说，还是非常效率。这本杂志在内分泌领域名声也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJibaCmkqDh1szchx6ZxPAKibTfzKVhZqTYn652p3NOPmswFfu95nic6R7rDJBABW6vdAAFxGgEucKA/0, createdBy=89752150161, createdName=脸圆圆学姐, createdTime=Sun Feb 16 15:35:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070872, encodeId=175810e0872e8, content=投稿之后就需要所有作者通过邮件确认吗？还是在接收之后才需要呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Nov 16 20:10:58 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570367, encodeId=f59f5e036785, content=大修回复过去编辑送外审还是直接编辑自己决定？第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细第一号第一号 2018-11-14 20:59:00 发表: 研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 02 00:00:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563203, encodeId=ca49563203bc, content=研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524c1935150, createdName=第一号第一号, createdTime=Wed Nov 14 20:57:00 CST 2018, time=2018-11-14, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

关键词能否从题目中提炼？

57 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1247737, encodeId=c453124e7372b, content=请问这个期刊不OA的话还收版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac4f6476577, createdName=ms3000000912488688, createdTime=Wed Sep 07 19:00:43 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571030, encodeId=02c55e1030f7, content=大修回去后Awaiting AE Recommendation，要多久啊大概最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。最夏天 2017-04-26 16:23:00 发表: 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, beContent=最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182544, encodeId=73601182544f0, content=一审：2021.10.12-2021.11.14。需要注意杂志是双盲，因此花费了一些时间在通过技术审查上。二审：2021.11.24-2021.12.9。12.2才开始外审，差不多在技术编辑手上呆了一个星期。三审：2021.12.20-12.30。26号结束外审，30号accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9615485584, createdName=加油顺顺利利, createdTime=Sun Jan 09 16:04:07 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198295, encodeId=75dd1198295f1, content=偏重的研究方向：甲状腺 经验分享：一审大修，二审半个月后直接决定，没有送审，这种情况是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/f1848b9cd6a75f497bebcc3b4dc4cbf3.jpg, createdBy=2f2a5173746, createdName=老虎🐯, createdTime=Tue Mar 01 10:27:20 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101548, encodeId=96db110154881, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101547, encodeId=7815110154e42, content=关键词能否从题目中提炼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584830, encodeId=ab345848308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一审：24-Sep-2019，29-Oct-2019。给了大修。两个审稿人，还是比较认真的，总共有二十几条意见。 二审：26-Nov-2019，29-Dec-2019。给了小修，因为response里的一些图表没有上传。 三审：05-Jan-2020，14-Feb-2020。接收。 总体来说，还是非常效率。这本杂志在内分泌领域名声也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJibaCmkqDh1szchx6ZxPAKibTfzKVhZqTYn652p3NOPmswFfu95nic6R7rDJBABW6vdAAFxGgEucKA/0, createdBy=89752150161, createdName=脸圆圆学姐, createdTime=Sun Feb 16 15:35:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070872, encodeId=175810e0872e8, content=投稿之后就需要所有作者通过邮件确认吗？还是在接收之后才需要呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Nov 16 20:10:58 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570367, encodeId=f59f5e036785, content=大修回复过去编辑送外审还是直接编辑自己决定？第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细第一号第一号 2018-11-14 20:59:00 发表: 研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 02 00:00:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563203, encodeId=ca49563203bc, content=研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524c1935150, createdName=第一号第一号, createdTime=Wed Nov 14 20:57:00 CST 2018, time=2018-11-14, status=1, ipAttribution=)]

2020-02-16 脸圆圆学姐

审稿速度:2.0 | 投稿命中率:50.0
经验分享：一审：24-Sep-2019，29-Oct-2019。给了大修。两个审稿人，还是比较认真的，总共有二十几条意见。
二审：26-Nov-2019，29-Dec-2019。给了小修，因为response里的一些图表没有上传。
三审：05-Jan-2020，14-Feb-2020。接收。
总体来说，还是非常效率。这本杂志在内分泌领域名声也不错。

153 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1247737, encodeId=c453124e7372b, content=请问这个期刊不OA的话还收版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac4f6476577, createdName=ms3000000912488688, createdTime=Wed Sep 07 19:00:43 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571030, encodeId=02c55e1030f7, content=大修回去后Awaiting AE Recommendation，要多久啊大概最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。最夏天 2017-04-26 16:23:00 发表: 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, beContent=最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182544, encodeId=73601182544f0, content=一审：2021.10.12-2021.11.14。需要注意杂志是双盲，因此花费了一些时间在通过技术审查上。二审：2021.11.24-2021.12.9。12.2才开始外审，差不多在技术编辑手上呆了一个星期。三审：2021.12.20-12.30。26号结束外审，30号accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9615485584, createdName=加油顺顺利利, createdTime=Sun Jan 09 16:04:07 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198295, encodeId=75dd1198295f1, content=偏重的研究方向：甲状腺 经验分享：一审大修，二审半个月后直接决定，没有送审，这种情况是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/f1848b9cd6a75f497bebcc3b4dc4cbf3.jpg, createdBy=2f2a5173746, createdName=老虎🐯, createdTime=Tue Mar 01 10:27:20 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101548, encodeId=96db110154881, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101547, encodeId=7815110154e42, content=关键词能否从题目中提炼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584830, encodeId=ab345848308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一审：24-Sep-2019，29-Oct-2019。给了大修。两个审稿人，还是比较认真的，总共有二十几条意见。 二审：26-Nov-2019，29-Dec-2019。给了小修，因为response里的一些图表没有上传。 三审：05-Jan-2020，14-Feb-2020。接收。 总体来说，还是非常效率。这本杂志在内分泌领域名声也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJibaCmkqDh1szchx6ZxPAKibTfzKVhZqTYn652p3NOPmswFfu95nic6R7rDJBABW6vdAAFxGgEucKA/0, createdBy=89752150161, createdName=脸圆圆学姐, createdTime=Sun Feb 16 15:35:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070872, encodeId=175810e0872e8, content=投稿之后就需要所有作者通过邮件确认吗？还是在接收之后才需要呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Nov 16 20:10:58 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570367, encodeId=f59f5e036785, content=大修回复过去编辑送外审还是直接编辑自己决定？第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细第一号第一号 2018-11-14 20:59:00 发表: 研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 02 00:00:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563203, encodeId=ca49563203bc, content=研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524c1935150, createdName=第一号第一号, createdTime=Wed Nov 14 20:57:00 CST 2018, time=2018-11-14, status=1, ipAttribution=)]

2021-11-16 wkw0722

投稿之后就需要所有作者通过邮件确认吗？还是在接收之后才需要呀

67 0

[GetPortalCommentsPageByObjectIdResponse(id=1247737, encodeId=c453124e7372b, content=请问这个期刊不OA的话还收版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac4f6476577, createdName=ms3000000912488688, createdTime=Wed Sep 07 19:00:43 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571030, encodeId=02c55e1030f7, content=大修回去后Awaiting AE Recommendation，要多久啊大概最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。最夏天 2017-04-26 16:23:00 发表: 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, beContent=最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182544, encodeId=73601182544f0, content=一审：2021.10.12-2021.11.14。需要注意杂志是双盲，因此花费了一些时间在通过技术审查上。二审：2021.11.24-2021.12.9。12.2才开始外审，差不多在技术编辑手上呆了一个星期。三审：2021.12.20-12.30。26号结束外审，30号accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9615485584, createdName=加油顺顺利利, createdTime=Sun Jan 09 16:04:07 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198295, encodeId=75dd1198295f1, content=偏重的研究方向：甲状腺 经验分享：一审大修，二审半个月后直接决定，没有送审，这种情况是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/f1848b9cd6a75f497bebcc3b4dc4cbf3.jpg, createdBy=2f2a5173746, createdName=老虎🐯, createdTime=Tue Mar 01 10:27:20 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101548, encodeId=96db110154881, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101547, encodeId=7815110154e42, content=关键词能否从题目中提炼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584830, encodeId=ab345848308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一审：24-Sep-2019，29-Oct-2019。给了大修。两个审稿人，还是比较认真的，总共有二十几条意见。 二审：26-Nov-2019，29-Dec-2019。给了小修，因为response里的一些图表没有上传。 三审：05-Jan-2020，14-Feb-2020。接收。 总体来说，还是非常效率。这本杂志在内分泌领域名声也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJibaCmkqDh1szchx6ZxPAKibTfzKVhZqTYn652p3NOPmswFfu95nic6R7rDJBABW6vdAAFxGgEucKA/0, createdBy=89752150161, createdName=脸圆圆学姐, createdTime=Sun Feb 16 15:35:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070872, encodeId=175810e0872e8, content=投稿之后就需要所有作者通过邮件确认吗？还是在接收之后才需要呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Nov 16 20:10:58 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570367, encodeId=f59f5e036785, content=大修回复过去编辑送外审还是直接编辑自己决定？第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细第一号第一号 2018-11-14 20:59:00 发表: 研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 02 00:00:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563203, encodeId=ca49563203bc, content=研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524c1935150, createdName=第一号第一号, createdTime=Wed Nov 14 20:57:00 CST 2018, time=2018-11-14, status=1, ipAttribution=)]

2019-05-02 12244fb8m28(暂无昵称)

大修回复过去编辑送外审还是直接编辑自己决定？第一号第一号 2018-11-14 发表::
研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细第一号第一号 2018-11-14 20:59:00 发表:
研究领域：甲状腺
04-Sep-2018 submitted
29-Oct-2018 major revisions
14-Nov-2018 Accepted
一审时间偏长编辑意见不多，审稿人意见较细

第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细

153 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1247737, encodeId=c453124e7372b, content=请问这个期刊不OA的话还收版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac4f6476577, createdName=ms3000000912488688, createdTime=Wed Sep 07 19:00:43 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571030, encodeId=02c55e1030f7, content=大修回去后Awaiting AE Recommendation，要多久啊大概最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。最夏天 2017-04-26 16:23:00 发表: 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, beContent=最夏天 2017-04-26 发表:: 接收率：约50% 审稿时间：约3个月 SCI(2015)：2.074 SCI(2014)：2.811 审稿周期较长，一审三个月，经过一次大修一次小修终于接受，总耗时5个多月。新手小硕表示不是很难。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182544, encodeId=73601182544f0, content=一审：2021.10.12-2021.11.14。需要注意杂志是双盲，因此花费了一些时间在通过技术审查上。二审：2021.11.24-2021.12.9。12.2才开始外审，差不多在技术编辑手上呆了一个星期。三审：2021.12.20-12.30。26号结束外审，30号accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9615485584, createdName=加油顺顺利利, createdTime=Sun Jan 09 16:04:07 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198295, encodeId=75dd1198295f1, content=偏重的研究方向：甲状腺 经验分享：一审大修，二审半个月后直接决定，没有送审，这种情况是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/f1848b9cd6a75f497bebcc3b4dc4cbf3.jpg, createdBy=2f2a5173746, createdName=老虎🐯, createdTime=Tue Mar 01 10:27:20 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101548, encodeId=96db110154881, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101547, encodeId=7815110154e42, content=关键词能否从题目中提炼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584830, encodeId=ab345848308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一审：24-Sep-2019，29-Oct-2019。给了大修。两个审稿人，还是比较认真的，总共有二十几条意见。 二审：26-Nov-2019，29-Dec-2019。给了小修，因为response里的一些图表没有上传。 三审：05-Jan-2020，14-Feb-2020。接收。 总体来说，还是非常效率。这本杂志在内分泌领域名声也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIJibaCmkqDh1szchx6ZxPAKibTfzKVhZqTYn652p3NOPmswFfu95nic6R7rDJBABW6vdAAFxGgEucKA/0, createdBy=89752150161, createdName=脸圆圆学姐, createdTime=Sun Feb 16 15:35:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070872, encodeId=175810e0872e8, content=投稿之后就需要所有作者通过邮件确认吗？还是在接收之后才需要呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Nov 16 20:10:58 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570367, encodeId=f59f5e036785, content=大修回复过去编辑送外审还是直接编辑自己决定？第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细第一号第一号 2018-11-14 20:59:00 发表: 研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=第一号第一号 2018-11-14 发表:: 研究方向：甲状腺;; 接收率：约50% 审稿时间：约3个月研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37f82318560, createdName=12244fb8m28(暂无昵称), createdTime=Thu May 02 00:00:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563203, encodeId=ca49563203bc, content=研究领域：甲状腺 04-Sep-2018 submitted 29-Oct-2018 major revisions 14-Nov-2018 Accepted 一审时间偏长编辑意见不多，审稿人意见较细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524c1935150, createdName=第一号第一号, createdTime=Wed Nov 14 20:57:00 CST 2018, time=2018-11-14, status=1, ipAttribution=)]

2018-11-14 第一号第一号

研究领域：甲状腺
04-Sep-2018 submitted
29-Oct-2018 major revisions
14-Nov-2018 Accepted
一审时间偏长编辑意见不多，审稿人意见较细

230 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务